Q'Apel Website Imagery - World

Where did our name come from?

We’re called Q’Apel for the Qu’Appelle River, a waterway that winds through Saskatchewan, Canada. Why? Because this pristine river charts a winding path, full of twists, turns, and straightaways alike. That’s what we do, too. Our cutting-edge products—neurological catheters, specifically—are designed to navigate the twists and turns of the brain’s neurovasculature, empowering therapeutic thrombectomy and cerebral aneurysm devices to deliver life-changing outcomes.

Who We Are
View All Resources

Q’Apel Medical announces FDA clearance for Walrus Balloon Guide Catheter.

July 17, 2019

Q’Apel Medical announced today that it received U.S. Food and Drug Administration clearance for its novel walrus Balloon Guide Catheter (BGC).

In the neurovascular space where speed, reliability, and performance are so critical to patient outcomes, physicians and patients demand that innovative technologies are best-in-class. The walrus BGC, with its 087 ID, marks a big step forward in balloon guide catheter technology and for stroke patients worldwide.

Catheter compatibility in the neurovascular space is critical to the treatment of stroke patients. Until now, widespread adoption of BGCs has been limited due to technical constraints. The walrus BGC was specifically designed to address these technical shortcomings with an 087 ID in a highly trackable catheter platform

Raymond Turner MD, professor of neurosurgery at Prisma Health

“I expect its introduction will be welcomed by neurovascular physicians everywhere.”

The walrus BGC represents the second FDA-cleared technology from Q’Apel in the past 12 months, joining the wahoo Access Catheter with Selectflex technology in Q’Apel’s expanding product portfolio. Q’Apel has several more innovative products slated to come to market over the course of the next year.

Press release link:
https://www.newswire.com/news/qapel-medical-announces-fda-clearance-for-walrus-balloon-guide-catheter-20948858

Related readings.

Our utmost commitment: creating what works based specifically and urgently on what’s needed. Explore additional resources, publications, and webinars to learn more.

May 20, 2021

Q’Apel Medical Welcomes Jodie Fam, Vice President and General Manager, International

February 11, 2021

Q’Apel Medical Raises $22 Million to Grow Highly Innovative Neurovascular Access Platform & Scott Huennekens joins Board of Directors

May 21, 2020

Walrus early experience webinar.

May 21, 2020

The early experience, techniques, and best practices used at State University of NY at Stony Brook with Walrus Balloon Guide Catheter.